Stay updated on Recombinant Protein Vaccine Clinical Trial

Sign up to get notified when there's something new on the Recombinant Protein Vaccine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant Protein Vaccine Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision tag to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/operating status notice (lapse in funding and NIH operations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:05:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added results information and IPD/data-sharing plan for NCT04762680. Updated study record dates and related results sections.
    Difference
    0.2%
    Check dated 2025-11-03T01:30:54.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    1%
    Check dated 2025-10-05T10:34:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.0%
    Check dated 2025-09-28T03:25:02.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Expanded and clarified safety and immunogenicity endpoints (AEs, SAEs, AESIs, MAAEs; GMTs, GMCs, seroresponses; infection outcomes) across multiple phases/cohorts; removes some earlier, narrower responder definitions and immediate-event items.
    Difference
    67%
    Check dated 2025-09-20T22:16:07.000Z thumbnail image

Stay in the know with updates to Recombinant Protein Vaccine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant Protein Vaccine Clinical Trial page.